Novel insights into bile acid detoxification via CYP, UGT and SULT enzymes.
Bile acid metabolism
CYP3A4
Glucuronidation
LCA
Lithocholic acid
Sulfation
Journal
Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
29
06
2022
revised:
28
10
2022
accepted:
02
12
2022
pubmed:
7
12
2022
medline:
3
1
2023
entrez:
6
12
2022
Statut:
ppublish
Résumé
Bile acid (BA) homeostasis is a complex and precisely regulated process to prevent impaired BA flow and the development of cholestasis. Several reactions, namely hydroxylation, glucuronidation and sulfation are involved in BA detoxification. In the present study, we employed a comprehensive approach to identify the key enzymes involved in BA metabolism using human recombinant enzymes, human liver microsomes (HLM) and human liver cytosol (HLC). We showed that CYP3A4 was a crucial step for the metabolism of several BAs and their taurine and glycine conjugated forms and quantitatively described their metabolites. Glucuronidation and sulfation were also identified as important drivers of the BA detoxification process in humans. Moreover, lithocholic acid (LCA), the most hydrophobic BA with the highest toxicity potential, was a substrate for all investigated processes, demonstrating the importance of hepatic metabolism for its clearance. Collectively, this study identified CYP3A4, UGT1A3, UGT2B7 and SULT2A1 as the major contributing (metabolic) processes in the BA detoxification network. Inhibition of these enzymes by drug candidates is therefore considered as a critical mechanism in the manifestation of drug-induced cholestasis in humans and should be addressed during the pre-clinical development.
Identifiants
pubmed: 36473578
pii: S0887-2333(22)00231-4
doi: 10.1016/j.tiv.2022.105533
pii:
doi:
Substances chimiques
Bile Acids and Salts
0
Cytochrome P-450 CYP3A
EC 1.14.14.1
Glucuronosyltransferase
EC 2.4.1.17
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
105533Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest None of the authors has any conflict of interest to this study to declare.